| Title |
Unmasking a silent threat: improving pulmonary hypertension screening methods for interstitial lung disease patients / |
| Authors |
Averjanovaitė, Vaida ; Gumbienė, Lina ; Zeleckienė, Ingrida ; Šileikienė, Virginija |
| DOI |
10.3390/medicina60010058 |
| Full Text |
|
| Is Part of |
Medicina (Lithuania).. Basel : MDPI. 2024, vol. 60, iss. 1, art. no. 58, p. [1-19].. ISSN 1010-660X. eISSN 1648-9144 |
| Keywords [eng] |
cardiac magnetic resonance imaging ; cardiopulmonary exercise testing ; echocardiography ; interstitial lung disease ; lung function tests ; pulmonary hypertension |
| Abstract [eng] |
This article provides a comprehensive overview of the latest literature on the diagnostics and treatment of pulmonary hypertension (PH) associated with interstitial lung disease (ILD). Heightened suspicion for PH arises when the advancement of dyspnoea in ILD patients diverges from the expected pattern of decline in pulmonary function parameters. The complexity of PH associated with ILD (PH-ILD) diagnostics is emphasized by the limitations of transthoracic echocardiography in the ILD population, necessitating the exploration of alternative diagnostic approaches. Cardiac magnetic resonance imaging (MRI) emerges as a promising tool, offering insights into hemodynamic parameters and providing valuable prognostic information. The potential of biomarkers, alongside pulmonary function and cardiopulmonary exercise tests, is explored for enhanced diagnostic and prognostic precision. While specific treatments for PH-ILD remain limited, recent studies on inhaled treprostinil provide new hope for improved patient outcomes. |
| Published |
Basel : MDPI |
| Type |
Journal article |
| Language |
English |
| Publication date |
2024 |
| CC license |
|
